07 June 2017

KWM celebrates a new chapter for its EUME network

On 5 June, partners from King & Wood Mallesons’ (KWM) international network and over 120 clients and guests gathered at London’s Guildhall Art Gallery to celebrate a new chapter for the firm in the UK, Europe and the Middle East (EUME). More than 60 KWM partners attended, from the firm’s UK, Europe, Middle East, China, Hong Kong and Australia offices.

Addressing clients at the London event, KWM Global Chairman, Wang Junfeng, said, “Today marks a new chapter of KWM EUME. As part of our unwavering commitment to this part of the world, we will continue to build and strengthen our presence in the UK and elsewhere in EUME. A strong foothold in this region is essential for us to continue to work with our clients operating or investing here. We are excited about the future: there are vast opportunities for our European clients in the Asia region and vice versa for our Asian clients, including the One Belt One Road initiative (OBOR). This is a key area for us as a firm as it is not only important to our clients but also touches upon every area of our legal practice.”

KWM’s EUME platform consists of offices in London, Frankfurt, Madrid, Brussels, Milan and Dubai. The platform focuses on Corporate M&A, Finance, Competition and Dispute Resolution.

Media Contact

Share on LinkedIn Share on Facebook Share on Twitter Share on Google+
    You might also be interested in

    The project is the first Tesla factory outside the US, and also thus far the largest foreign-invested manufacturing project in Shanghai.

    16 July 2018

    The successful completion of this high-profile transaction marks one of the most significant financings in China’s entertainment industry in the first half of 2018.

    13 July 2018

    KWM team is led by partners Xiao Jin, Xue Han, and Liu Cheng.

    10 July 2018

    King & Wood Mallesons’ cross-border team, advised Luye Pharma Hong Kong Limited (“Luye Pharma”) on its transaction signed with AstraZeneca relating to the sale and licence of the rights to Seroquel...

    09 May 2018

    This publication has been downloaded from the King & Wood Mallesons website. It is provided only for your information and does not constitute legal or other advice on any specific matter. If you require or seek legal advice you should obtain such advice from your own lawyer, and should do so before taking, or refraining from taking, any action in reliance on this publication. If you have any questions, please contact King & Wood Mallesons. See www.kwm.com for more information.